Larvol Delta - FDA-grants-IDE-approval-to-use-Oncology-Ventures-LiPlaCis-DRP-for-patient-selection-in-a-pivotal-Phase-3-study

cisplatin - Generic Mfg.

LiPlaCis (liposomal cisplatin) - Oncology Venture

http://www.globenewswire.com/news-release/2019/08/15/1902690/0/en/FDA-grants-IDE-approval-to-use-Oncology-Venture-s-LiPlaCis-DRP-for-patient-selection-in-a-pivotal-Phase-3-study.html

Aug 15, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next